Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2016
Quantification of RSV Infectious Particles by Plaque Assay and Immunostaining AssayPatricia A Jorquera, Ralph A TrippExpert Review of Respiratory Medicine|June 3, 2017
Respiratory syncytial virus: prospects for new and emerging therapeuticsPatricia A Jorquera, Ralph A TrippVaccines|December 6, 2016
Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusPatricia A Jorquera, Ralph A TrippMethods in Molecular Biology (Clifton, N.J.)|July 29, 2016
Human Respiratory Syncytial Virus: An IntroductionPatricia A Jorquera, Lydia Anderson, Ralph A TrippMethods in Molecular Biology (Clifton, N.J.)|July 29, 2016
MicroRNA Profiling from RSV-Infected Biofluids, Whole Blood, and Tissue SamplesLydia Anderson, Patricia A Jorquera, Ralph A TrippExpert Review of Vaccines|December 8, 2015
Understanding respiratory syncytial virus (RSV) vaccine development and aspects of disease pathogenesisPatricia A Jorquera, Lydia Anderson, Ralph A TrippExpert Review of Respiratory Medicine|August 23, 2013
Advances in and the potential of vaccines for respiratory syncytial virusPatricia A Jorquera, Katie E Oakley, Ralph A TrippFrontiers in Immunology|October 26, 2019
Determining Immune and miRNA Biomarkers Related to Respiratory Syncytial Virus (RSV) Vaccine TypesLydia J Atherton, Patricia A Jorquera, Abhijeet A Bakre, et al.Viral Immunology|May 4, 2012
Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strainsYoungjoo Choi, Caleb S Mason, Les P Jones, et al.Vaccines|October 17, 2015
Layer-By-Layer Nanoparticle Vaccines Carrying the G Protein CX3C Motif Protect against RSV Infection and DiseasePatricia A Jorquera, Katie E Oakley, Thomas J Powell, et al.Pageof 2